Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

spantide III

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Neuropeptide substance P (SP) has been implicated in inflammation, pain, depression and breast cancer cell (BCC) growth. Here, we… Expand
Is this relevant?
2012
2012
Skin pigmentation plays a number of valuable roles and its regulation is a complex process that is controlled by different… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BackgroundAcute cutaneous neurogenic inflammation initiated by activation of transient receptor potential vanilloid-1 (TRPV1… Expand
  • figure 7
Is this relevant?
2006
2006
BACKGROUND There is increasing evidence that neuropeptides, especially substance P (SP), may be involved in the pathogenesis of… Expand
Is this relevant?
2005
2005
Neurokinin receptors (NK1, NK2, NK3) are G-protein-coupled receptors, which upon activation by a peptide agonist induce a… Expand
Is this relevant?
1998
1998
We have investigated the effects of the substance P C-terminal octapeptide analogues [Pro4, Glu (OBzl)11] SP4-11, [Hyp4, Glu(OBzl… Expand
Is this relevant?
1998
1998
Because substance p (SP) has been reported to be released from cutaneous sensory nerve endings after hapten application, we… Expand
Is this relevant?
1997
1997
1. Electroconvulsive treatment (ECT) of rabbits produced ocular inflammation consisting of conjunctival hyperaemia, miosis and… Expand
Is this relevant?
1991
1991
We compared the ability of spantide I and II to antagonize tachykinins in monoreceptor bioassays. Both peptides antagonized the… Expand
Is this relevant?
1990
1990
The effects of unilateral injections of two substance P fragments, the N-terminal substance P (1-7) (SP1-7) and the C-terminal… Expand
Is this relevant?